Phosphorylation at S724 is a hallmark of ERN1 activation. This site lies within the kinase activation loop, enabling autophosphorylation and subsequent activation of its endoribonuclease domain. Key functions include:
UPR Activation: Triggers splicing of XBP1 mRNA, producing a transcription factor that upregulates stress-response genes .
ER Stress Signaling: Critical for resolving protein misfolding in the ER via XBP1-dependent pathways .
Cross-Species Conservation: S724 phosphorylation is conserved in human, mouse, and rat models .
The antibody is widely used to detect ERN1 phosphorylation in cellular lysates under ER stress.
Key Insight: In Ern1 S724A/S724A mice, phosphorylation at S724 is undetectable, confirming the antibody’s specificity .
Used to localize ERN1 in stressed cells.
Protocol: Fixed HeLa cells (4% formaldehyde), permeabilized (0.2% Triton X-100), blocked (10% goat serum), and incubated with antibody overnight .
Outcome: Cytoplasmic ERN1 signal with DAPI counterstaining .
Validated in paraffin-embedded human spleen tissue (1:300 dilution) with hematoxylin counterstaining .
The recombinant monoclonal variant (e.g., CSB-RA007795A724phHU) outperforms traditional polyclonal antibodies in specificity and lot consistency.
XBP1 Splicing: S724 phosphorylation is essential for IRE1α’s RNase activity. In Ern1 S724A/S724A mice, XBP1 splicing is blunted under tunicamycin-induced stress, leading to exacerbated hepatic steatosis .
RIDD Activity: While S724 phosphorylation primarily drives XBP1 splicing, its absence may shift IRE1α toward regulated IRE1-dependent decay (RIDD) of other mRNAs .
Cancer and Metabolic Disorders: ERN1 S724 phosphorylation is implicated in tumor adaptation to hypoxia and metabolic stress .
Neurodegeneration: Dysregulated UPR pathways, including IRE1α activation, are linked to neurodegenerative diseases .
The Phospho-ERN1 (S724) Recombinant Monoclonal Antibody is generated by cloning the coding sequence for the phospho-ERN1 (S724) monoclonal antibody (produced by immunizing animals with the synthetic phosphopeptide of ERN1) into plasmids and transfecting the clones into cell lines. This antibody is a rabbit IgG purified using affinity chromatography. The Phospho-ERN1 (S724) antibody specifically detects endogenous levels of human ERN1 only when phosphorylated at Ser724. This antibody can be used in ELISA, Western Blot (WB), and Immunofluorescence (IF) analyses.
Phosphorylation at Ser724 residue of the ERN1 protein is crucial for regulating its transcriptional and enzymatic activities. Phospho-ERN1 (S724) antibodies are valuable tools to analyze ERN1 Ser724 phosphorylation, a highly conserved site within the kinase activation domain.
ERN1 (also known as IRE1α) is a serine/threonine-protein kinase and endoribonuclease that plays a critical role as a sensor for the endoplasmic reticulum unfolded protein response (UPR). In unstressed cells, the endoplasmic reticulum luminal domain of ERN1 is maintained in its inactive monomeric state by binding to the endoplasmic reticulum chaperone HSPA5/BiP. The accumulation of misfolded proteins in the endoplasmic reticulum leads to the release of HSPA5/BiP, allowing the luminal domain to homodimerize, triggering autophosphorylation of the kinase domain and subsequent activation of the endoribonuclease activity.
The endoribonuclease activity of ERN1 is specific for XBP1 mRNA, excising 26 nucleotides from it. This splicing event generates a spliced transcript of XBP1, encoding a transcriptional activator protein that upregulates expression of UPR target genes. ERN1 also acts as an upstream signal for ER stress-induced GORASP2-mediated unconventional (ER/Golgi-independent) trafficking of CFTR to the cell membrane by modulating the expression and localization of SEC16A.
Applications : Immunoblot analysis
Sample type: cell
Review: Immunoblot analysis of IRE1α in lysates of Kupffer cells and hepatocytes freshly isolated from livers of male MΦKO mice or Ern1-flox/flox control littermates. HSP90 was used as the loading control. B–E, MΦKO or floxed control mice were subjected to sham or hepatic warm ischemia/reperfusion (n=3–4 per group).